Research Article

The Role of the Basal Core Promoter (BCP) and Precore Codon 28 Mutations in the Treatment Response to the Pegylated Interferon
  • Şükran KÖSE
  • Süheyla Serin SENGER
  • Gülsün ÇAVDAR
  • Pelin ADAR
Viral Hepat J 2014; 20: 19-22 DOI: 10.4274/Vhd.74946

Research Article

Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha
  • Handan ALAY
  • Kemalettin ÖZDEN
  • Serpil EROL
  • Neslihan ÇELİK
  • Emine PARLAK
  • Mehmet PARLAK
Viral Hepat J 2018; 24: 25-42 DOI: 10.4274/vhd.2017.0016

Other

Effect of IFN-a2a Treatment Upon Serum IL-1ß, IL-6,TNF-aand Neopterin Levels in Patients with Chronic Viral Hepatitis B
  • Mehmet YALNIZ
  • Fulya ILHAN
  • Hüseyin ATASEVEN
  • Necip ILHAN
  • I. Halil BAHÇECIOGLU
Viral Hepat J 2004; 9: 18-23
Evaluation of Thyroid Functions During Interferon-Alpha Treatment ofPatients with Chronic Viral Hepatitis
  • Mustafa SÜNBÜL
  • Ertan SAHBAT
  • Mehmet AKKUS
  • Saban ESEN
  • Hakki KAHRAMAN
  • Hakan LEBLEBICIOGLU
Viral Hepat J 2004; 9: 67-71
Interferon Therapy in Chronic Hepatitis B Infection
  • Yesim TASOVA
  • Nese SALTOGLU
  • Özlem ERDURAK
  • Hasan S.Z. AKSU
Viral Hepat J 1996; 2: 96-102
INTERFERON TREATMENT AND ITS RESULTS IN CHRONIC HEPATITIS 8
  • Fatma SIRMATEL
  • Mehmet CANDAN
  • GönüI BAKIR
  • Öcal SIRMATEL
  • Kemal BAKIR
Viral Hepat J 2002; 8: 525-528